Hydrocortisone acetate 2.5 % / pramoxine hydrochloride 1 % Emollient Base Topical Cream
RxNorm 1801281
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1801281 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: hydrocortisone acetate 2.5 % / pramoxine hydrochloride 1 % Emollient Base Topical Cream.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Emollient hydrocortisone acetate 25 mg/ML / pramoxine hydrochloride 10 mg/ML Topical Cream
(Atom ID: 12334378)
PSN
Prescribable Name (PSN):
Hydrocortisone acetate 2.5 % / pramoxine hydrochloride 1 % Emollient Base Topical Cream
(Atom ID: 8237573)
SY
Synonym (SY):
Hydrocortisone acetate 2.5 % / pramoxine hydrochloride 1 % Emollient Base Topical Cream
(Atom ID: 8237572)
Patient Education
Hydrocortisone Topical
Hydrocortisone topical is used to treat redness, swelling, itching, and discomfort of various skin conditions. Hydrocortisone is in a class of medications called corticosteroids. It works by activating natural substances in the skin to reduce swelling, redness, and itching.
[Learn More]
Pramoxine
Pramoxine is used to temporarily relieve pain and itching from insect bites; poison ivy, poison oak, or poison sumac; minor cuts, scrapes, or burns; minor skin irritation or rashes; or dry, itchy skin. Pramoxine also may be used to treat soreness, burning, itching, and pain from hemorrhoids (''piles'') and other minor rectal irritations or itching. Pramoxine is in a class of medications called topical anesthetics. It works by stopping nerves from sending pain signals.
[Learn More]
* Please review the disclaimer below.